| Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 852 | 2021 |
| BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 447 | 2021 |
| Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 446 | 2022 |
| Three Indonesian clusters of H5N1 virus infection in 2005 IN Kandun, H Wibisono, ER Sedyaningsih, Yusharmen, ... New England Journal of Medicine 355 (21), 2186-2194, 2006 | 442 | 2006 |
| Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 407 | 2022 |
| mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021 | 403 | 2021 |
| Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 360 | 2022 |
| Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting LJ Abu-Raddad, H Chemaitelly, JA Malek, AA Ahmed, YA Mohamoud, ... Clinical Infectious Diseases 73 (7), e1830-e1840, 2021 | 239 | 2021 |
| Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 220 | 2022 |
| SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ... EClinicalMedicine 35, 2021 | 190 | 2021 |
| Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ... Jama 326 (19), 1930-1939, 2021 | 149 | 2021 |
| COVID-19 infection among healthcare workers in a national healthcare system: The Qatar experience J Alajmi, AM Jeremijenko, JC Abraham, M Alishaq, EG Concepcion, ... International Journal of Infectious Diseases 100, 386-389, 2020 | 147 | 2020 |
| Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic LJ Abu-Raddad, H Chemaitelly, HH Ayoub, Z Al Kanaani, A Al Khal, ... Scientific reports 11 (1), 6233, 2021 | 137 | 2021 |
| COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar J Saththasivam, SS El-Malah, TA Gomez, KA Jabbar, R Remanan, ... Science of the Total Environment 774, 145608, 2021 | 132 | 2021 |
| Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ... New England Journal of Medicine 387 (17), 1620-1622, 2022 | 111 | 2022 |
| Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar LJ Abu-Raddad, H Chemaitelly, R Bertollini New England Journal of Medicine 386 (11), 1091-1093, 2022 | 94 | 2022 |
| Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 AS Omrani, SA Pathan, SA Thomas, TRE Harris, PV Coyle, CE Thomas, ... EClinicalMedicine 29, 2020 | 91 | 2020 |
| Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses LJ Abu-Raddad, H Chemaitelly, HM Yassine, FM Benslimane, ... Journal of travel medicine 28 (7), taab083, 2021 | 88 | 2021 |
| Duration of immune protection of SARS-CoV-2 natural infection against reinfection H Chemaitelly, N Nagelkerke, HH Ayoub, P Coyle, P Tang, HM Yassine, ... Journal of Travel Medicine 29 (8), taac109, 2022 | 84 | 2022 |
| Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19 HH Ayoub, H Chemaitelly, S Seedat, M Makhoul, Z Al Kanaani, A Al Khal, ... Journal of Global Health 11, 2021 | 81 | 2021 |
Adeel A. ButtProfessor of Medicine and Professor of Population Health Sciences, Weill Cornell Medical CollegeVerified email at med.cornell.edu
